These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 21927980

  • 21. Gastrointestinal stromal tumor and its targeted therapeutics.
    Dupart J, Zhang W, Trent JC.
    Chin J Cancer; 2011 May; 30(5):303-14. PubMed ID: 21527063
    [Abstract] [Full Text] [Related]

  • 22. Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy.
    Annaberdyev S, Gibbons J, Hardacre JM.
    World J Surg Oncol; 2009 Mar 16; 7():30. PubMed ID: 19291285
    [Abstract] [Full Text] [Related]

  • 23. A Case of Disseminated Intra-abdominal Gastrointestinal Stromal Tumor Managed with Low Dose Imatinib.
    Jang BH, Kim BW, Lim KJ, Kim BG, Park SM, Kim JS, Ji JS, Choi H.
    Korean J Gastroenterol; 2015 Jun 16; 65(6):366-9. PubMed ID: 26087692
    [Abstract] [Full Text] [Related]

  • 24. A rare case of gastrointestinal stromal tumor presenting with closed perforation of the small intestine.
    Andican A, Gökçal F, Agayeva A, Gülşen F, Özden F, Özben V.
    Turk J Gastroenterol; 2012 Jun 16; 23(3):253-7. PubMed ID: 22798115
    [Abstract] [Full Text] [Related]

  • 25. Advanced or metastatic gastrointestinal stromal tumors: systemic treatment options.
    Caram MV, Schuetze SM.
    J Surg Oncol; 2011 Dec 16; 104(8):888-95. PubMed ID: 22069173
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of high-risk clinicopathological indicators in gastrointestinal stromal tumors for prognosis and imatinib treatment outcome.
    Zhao WY, Xu J, Wang M, Zhang ZZ, Tu L, Wang CJ, Cao H, Zhang ZG.
    BMC Gastroenterol; 2014 Jun 07; 14():105. PubMed ID: 24906683
    [Abstract] [Full Text] [Related]

  • 27. Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1.
    Lee JL, Kim JY, Ryu MH, Kang HJ, Chang HM, Kim TW, Lee H, Park JH, Kim HC, Kim JS, Kang YK.
    Dig Dis Sci; 2006 Jun 07; 51(6):1043-6. PubMed ID: 16865565
    [No Abstract] [Full Text] [Related]

  • 28. Complete pathological response in advanced extra-gastrointestinal stromal tumor after imatinib mesylate therapy: a case report.
    Rediti M, Pellegrini E, Molinara E, Cerullo C, Fonte C, Lunghi A, Iori A, Neri B.
    Anticancer Res; 2014 Feb 07; 34(2):905-7. PubMed ID: 24511030
    [Abstract] [Full Text] [Related]

  • 29. Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib.
    Lee CK, Goldstein D, Gibbs E, Joensuu H, Zalcberg J, Verweij J, Casali PG, Maki RG, Cioffi A, Mcarthur G, Lord SJ, Yip D, Kanjanapan Y, Rutkowski P.
    Eur J Cancer; 2015 May 07; 51(7):852-60. PubMed ID: 25801699
    [Abstract] [Full Text] [Related]

  • 30. Highlighting the role of FDG PET scan in early response assessment of gastrointestinal stromal tumor treated with imatinib mesylate.
    Abhyankar SA, Nair N.
    Clin Nucl Med; 2008 Mar 07; 33(3):213-4. PubMed ID: 18287851
    [No Abstract] [Full Text] [Related]

  • 31. [FDG-PET and CT in gastrointestinal stromal tumor treated with imatinib].
    Eigtved AI, Berthelsen AK, Kinnander C, Krarup-Hansen A.
    Ugeskr Laeger; 2003 Sep 08; 165(37):3507-9. PubMed ID: 14531350
    [Abstract] [Full Text] [Related]

  • 32. Gastrointestinal stromal tumours: etiology, pathology and clinical management.
    Blackstein ME, Dubé P, Fletcher JA, Keller OR, Knowling M, Létourneau R, Morris D, Riddell R, Rorke S, Swallow CJ, Canadian Advisory Committee on GIST.
    Can J Gastroenterol; 2004 Sep 08; 18 Suppl B():3B-8B. PubMed ID: 15457300
    [Abstract] [Full Text] [Related]

  • 33. [Clinical analysis of 156 patients with gastrointestinal stromal tumors receiving imatinib therapy].
    Zhang L, Cai M, Deng J, Wang X, Wang B, Liu N, Pan Y, Zhang R, Cui Q, Liang H.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr 08; 17(4):331-4. PubMed ID: 24760639
    [Abstract] [Full Text] [Related]

  • 34. [Chinese consensus in diagnosis and treatment of gastrointestinal stromal tumor].
    Chinese Diagnosis and Treatment Experts Group for Gastrointestinal Stromal Tumors.
    Zhonghua Bing Li Xue Za Zhi; 2009 Oct 08; 38(10):697-702. PubMed ID: 20078976
    [No Abstract] [Full Text] [Related]

  • 35. Primary GIST of the liver masquerading as primary intra-abdominal tumour: a rare extra-gastrointestinal stromal tumour (EGIST) of the liver.
    Louis AR, Singh S, Gupta SK, Sharma A.
    J Gastrointest Cancer; 2014 Sep 08; 45(3):392-4. PubMed ID: 23749608
    [No Abstract] [Full Text] [Related]

  • 36. Value of pharmacokinetic studies for patients with gastrointestinal stromal tumors.
    De Giorgi U.
    Future Oncol; 2013 Nov 08; 9(11):1675-7. PubMed ID: 23862700
    [No Abstract] [Full Text] [Related]

  • 37. [Successful resection of locally advanced gastrointestinal stromal tumor of the ampulla of Vater after treatment with imatinib].
    Park JE, Dong SH, Cho KH, Jang JY, Kim HJ, Kim BH, Chang YW, Chang R.
    Korean J Gastroenterol; 2010 Jul 08; 56(1):39-44. PubMed ID: 20695129
    [Abstract] [Full Text] [Related]

  • 38. The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study.
    Rutkowski P, Bylina E, Klimczak A, Switaj T, Falkowski S, Kroc J, Lugowska I, Brzeskwiniewicz M, Melerowicz W, Osuch C, Mierzejewska E, Wasielewski K, Woźniak A, Grzesiakowska U, Nowecki ZI, Siedlecki JA, Limon J.
    BMC Cancer; 2012 Mar 22; 12():107. PubMed ID: 22439647
    [Abstract] [Full Text] [Related]

  • 39. Imatinib and beyond in gastrointestinal stromal tumors: A radiologist's perspective.
    Tirumani SH, Jagannathan JP, Krajewski KM, Shinagare AB, Jacene H, Ramaiya NH.
    AJR Am J Roentgenol; 2013 Oct 22; 201(4):801-10. PubMed ID: 24059369
    [Abstract] [Full Text] [Related]

  • 40. Neoadjuvant therapy with imatinib mesylate for locally advanced GI stromal tumor.
    Shah JN, Sun W, Seethala RR, Livolsi VA, Fry RD, Ginsberg GG.
    Gastrointest Endosc; 2005 Apr 22; 61(4):625-7. PubMed ID: 15812427
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.